Loading...

Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening

The performance of cervical cancer screening will decline as a function of lower disease prevalence—a consequence of successful human papillomavirus (HPV) vaccination. Replacement of cytology with molecular HPV testing as the primary screening test and adoption of risk‐based screening, with less int...

Full description

Saved in:
Bibliographic Details
Published in:Int J Cancer
Main Authors: Tota, Joseph E., Isidean, Sandra D., Franco, Eduardo L.
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689748/
https://ncbi.nlm.nih.gov/pubmed/32588426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33178
Tags: Add Tag
No Tags, Be the first to tag this record!